These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 6295218)
41. Neuromuscular pharmacology. A clinical update and commentary. Lee C; Katz RL Br J Anaesth; 1980 Feb; 52(2):173-88. PubMed ID: 6244842 [No Abstract] [Full Text] [Related]
42. Pancuronium, vecuronium, and d-tubocurarine inhibit and succinylcholine stimulates choline acetyltransferase activity. Kambam JR; Janson VE; Day P; Sastry BV Can J Anaesth; 1990 Sep; 37(6):690-4. PubMed ID: 1976448 [TBL] [Abstract][Full Text] [Related]
43. The effects of acute and chronic hydrocortisone treatment on neuromuscular blockade in the anesthetized cat. Durant NN; Briscoe JR; Katz RL Anesthesiology; 1984 Aug; 61(2):144-50. PubMed ID: 6087696 [TBL] [Abstract][Full Text] [Related]
44. [Interaction of d-tubocurarine and pancuronium on neuromuscular transmission in man]. Yang CY; Ho ST; Lin C; Chang CL Ma Zui Xue Za Zhi; 1986 Jun; 24(2):105-10. PubMed ID: 3023782 [No Abstract] [Full Text] [Related]
46. In vitro comparison between the neuromuscular and ganglion blocking potency ratios of atracurium and tubocurarine. Healy TE; Palmer JP Br J Anaesth; 1982 Dec; 54(12):1307-11. PubMed ID: 6293522 [TBL] [Abstract][Full Text] [Related]
47. Comparison of muscle relaxants in clinical use. Ertama P; Mäkeläinen A Ann Chir Gynaecol; 1977; 66(2):113-9. PubMed ID: 141237 [TBL] [Abstract][Full Text] [Related]
48. Comparative antagonism of d-tubocurarine-, gallamine-, and pancuronium-induced neuromuscular blockades by neostigmine. Miller RD; Larson CP; Way WL Anesthesiology; 1972 Nov; 37(5):503-9. PubMed ID: 4263447 [No Abstract] [Full Text] [Related]
49. Lithium carbonate and neuromuscular blocking agents. Hill GE; Wong KC; Hodges MR Anesthesiology; 1977 Feb; 46(2):122-6. PubMed ID: 835845 [TBL] [Abstract][Full Text] [Related]
50. The influence of stimulation parameters on the potency and reversibility of neuromuscular blocking agents. Foldes FF; Chaudhry I; Ohta Y; Amaki Y; Nagashima H; Duncalf D J Neural Transm; 1981; 52(3):227-49. PubMed ID: 6118392 [TBL] [Abstract][Full Text] [Related]
51. Histamine liberation in surgical patients following administration of neuromuscular blocking drugs. Ertama PM Ann Clin Res; 1982 Feb; 14(1):15-26. PubMed ID: 6182834 [TBL] [Abstract][Full Text] [Related]
52. Clinical pharmacology of neuromuscular blocking agents. Fisher DM Am J Health Syst Pharm; 1999 Jun; 56(11 Suppl 1):S4-9. PubMed ID: 10437710 [TBL] [Abstract][Full Text] [Related]
53. Time course of muscle relaxation with a combination of pancuronium and tubocurarine. Mirakhur RK; Pandit SK; Ferres CJ; Gibson FM Anesth Analg; 1984 Apr; 63(4):437-40. PubMed ID: 6703370 [TBL] [Abstract][Full Text] [Related]
54. Modification of pancuronium-induced nondepolarizing neuromuscular block by succinylcholine in anesthetized humans. Buzello W; Krieg N; Kuhls E; Schlickewei A Anesthesiology; 1983 Dec; 59(6):573-6. PubMed ID: 6316814 [No Abstract] [Full Text] [Related]
55. The relation between tetanic fade and receptor occlusion in the presence of competitive neuromuscular block. Waud BE; Waud DR Anesthesiology; 1971 Nov; 35(5):456-64. PubMed ID: 4329144 [No Abstract] [Full Text] [Related]
56. [Differences between small doses of dTc and pancuronium in their effects upon the SCC Induced phase II block (author's transl)]. Kuze S; Aizawa Y; Nakanishi T; Toudo Y; Murakami S Masui; 1977 Dec; 26(13):1606-14. PubMed ID: 599650 [No Abstract] [Full Text] [Related]
57. Differential increase in potency of neuromuscular blocking agents by enflurane and halothane. Schuh FT Int J Clin Pharmacol Ther Toxicol; 1983 Aug; 21(8):383-6. PubMed ID: 6629542 [TBL] [Abstract][Full Text] [Related]